PMOD TECHNOLOGIES GMBH

PMOD TECHNOLOGIES GMBH specializes in the development and licensing of advanced medical imaging analysis software, with a focus on pixel-wise modeling tools for quantitative research and clinical applications. Their core capability centers on delivering high-precision computational platforms for nuclear medicine, oncology, and neuroimaging, enabling researchers and clinicians to extract quantitative biomarkers from PET, SPECT, and CT datasets. The company’s technical expertise lies in algorithmic image processing, dynamic modeling, and statistical analysis of radiotracer kinetics, with solutions designed to meet the rigorous validation requirements of biomedical research environments. Their proprietary tools support reproducible, standardized analysis workflows, differentiating them through domain-specific accuracy and regulatory-ready output formats used in multi-center trials and translational medicine. The contractor has demonstrated direct engagement with the Department of Health and Human Services, providing specialized software licenses for quantitative imaging analysis in public health and biomedical research initiatives. This relationship suggests alignment with NIH-funded programs and federal laboratories requiring validated, peer-reviewed computational tools for radiopharmaceutical evaluation and treatment response assessment. Their primary industry focus is in other computer-related services under NAICS 541519, specifically tailored to the life sciences sector. This positions them as a niche provider of computational biology software rather than general IT services, serving academic medical centers, government research institutes, and pharmaceutical R&D teams requiring FDA-aligned analytics platforms. PMOD TECHNOLOGIES GMBH operates as a small, privately held entity based in Faellanden, Switzerland, with no publicly disclosed government certifications. Their market presence is defined by technical specialization in medical imaging analytics rather than broad federal contracting scale, serving a global research community through direct software licensing and technical support.